During the past decade, Skånes University Hospital, Skånes Department of Onclology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Skånes University Hospital, Skånes Department of Onclology" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Lund University Hospital" with 3 trials sponsored, "Alligator Bioscience AB" with 1 trials sponsored, "BioInvent International AB" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Skånes University Hospital, Skånes Department of Onclology" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Skånes University Hospital, Skånes Department of Onclology" are "Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Osteosarcoma" (2 trials), "Acute Leukemia" (1 trials) and "B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Skånes University Hospital, Skånes Department of Onclology" in a lesser frequency.

Most popular intervention types in "Skånes University Hospital, Skånes Department of Onclology" are "Drug" (20 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Pertuzumab" (3 trials), "Placebo" (3 trials), "Cetuximab" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Skånes University Hospital, Skånes Department of Onclology" are 19 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Skånes University Hospital, Skånes Department of Onclology". 2 are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Skånes University Hospital, Skånes Department of Onclology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Skånes University Hospital, Skånes Department of Onclology, 6 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".